Litcius/Paper detail

A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2

Danesh Hassani, Mohammad Mehdi Amiri, Mehdi Mohammadi, Parisa Yousefi, Mohammad Ali Judaki, Maryam Mobini, Forough Golsaz‐Shirazi, Mahmood Jeddi‐Tehrani, Fazel Shokri

2021Current Research in Translational Medicine16 citationsDOI

Topics & Concepts

Monoclonal antibodyTrastuzumabFlow cytometryEpitopeAntibodyCancer researchImmunotherapyPertuzumabCancer cellCancer immunotherapyBiologyMAPK/ERK pathwayMolecular biologyCancerChemistrySignal transductionCell biologyImmunologyImmune systemBreast cancerGeneticsHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchRadiopharmaceutical Chemistry and Applications
A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2 | Litcius